nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Timolol—CYP2D6—breast cancer	0.00277	0.187	CrCbGaD
Levobunolol—Carteolol—CYP2D6—breast cancer	0.00247	0.167	CrCbGaD
Levobunolol—Timolol—ABCB1—breast cancer	0.00198	0.133	CrCbGaD
Levobunolol—Salbutamol—CYP3A4—breast cancer	0.00169	0.114	CrCbGaD
Levobunolol—Nadolol—ABCB1—breast cancer	0.00157	0.106	CrCbGaD
Levobunolol—Pindolol—CYP2D6—breast cancer	0.00138	0.0934	CrCbGaD
Levobunolol—Arrhythmia—Paclitaxel—breast cancer	0.00114	0.00125	CcSEcCtD
Levobunolol—Hypersensitivity—Melphalan—breast cancer	0.00114	0.00125	CcSEcCtD
Levobunolol—Conjunctivitis—Capecitabine—breast cancer	0.00113	0.00124	CcSEcCtD
Levobunolol—Asthenia—Tamoxifen—breast cancer	0.00113	0.00124	CcSEcCtD
Levobunolol—Chest pain—Gemcitabine—breast cancer	0.00113	0.00124	CcSEcCtD
Levobunolol—Alopecia—Paclitaxel—breast cancer	0.00113	0.00124	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—breast cancer	0.00112	0.00123	CcSEcCtD
Levobunolol—Confusional state—Mitoxantrone—breast cancer	0.00112	0.00123	CcSEcCtD
Levobunolol—Confusional state—Irinotecan—breast cancer	0.00112	0.00123	CcSEcCtD
Levobunolol—Pruritus—Tamoxifen—breast cancer	0.00112	0.00122	CcSEcCtD
Levobunolol—Feeling abnormal—Vinorelbine—breast cancer	0.00111	0.00122	CcSEcCtD
Levobunolol—Chest pain—Fluorouracil—breast cancer	0.00111	0.00122	CcSEcCtD
Levobunolol—Diarrhoea—Vinblastine—breast cancer	0.00111	0.00122	CcSEcCtD
Levobunolol—Hypersensitivity—Goserelin—breast cancer	0.00111	0.00122	CcSEcCtD
Levobunolol—Asthenia—Melphalan—breast cancer	0.00111	0.00121	CcSEcCtD
Levobunolol—Pain—Thiotepa—breast cancer	0.0011	0.00121	CcSEcCtD
Levobunolol—Shock—Mitoxantrone—breast cancer	0.00109	0.0012	CcSEcCtD
Levobunolol—Shock—Irinotecan—breast cancer	0.00109	0.0012	CcSEcCtD
Levobunolol—Pruritus—Melphalan—breast cancer	0.00109	0.0012	CcSEcCtD
Levobunolol—Hypoglycaemia—Epirubicin—breast cancer	0.00108	0.00118	CcSEcCtD
Levobunolol—Asthenia—Goserelin—breast cancer	0.00108	0.00118	CcSEcCtD
Levobunolol—Diarrhoea—Tamoxifen—breast cancer	0.00108	0.00118	CcSEcCtD
Levobunolol—Lethargy—Epirubicin—breast cancer	0.00108	0.00118	CcSEcCtD
Levobunolol—Cerebrovascular accident—Epirubicin—breast cancer	0.00108	0.00118	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—breast cancer	0.00108	0.00118	CcSEcCtD
Levobunolol—Confusional state—Fluorouracil—breast cancer	0.00107	0.00118	CcSEcCtD
Levobunolol—Dizziness—Vinblastine—breast cancer	0.00107	0.00118	CcSEcCtD
Levobunolol—Urticaria—Vinorelbine—breast cancer	0.00107	0.00117	CcSEcCtD
Levobunolol—Bradycardia—Capecitabine—breast cancer	0.00107	0.00117	CcSEcCtD
Levobunolol—Pruritus—Goserelin—breast cancer	0.00107	0.00117	CcSEcCtD
Levobunolol—Feeling abnormal—Thiotepa—breast cancer	0.00106	0.00116	CcSEcCtD
Levobunolol—Ataxia—Methotrexate—breast cancer	0.00106	0.00116	CcSEcCtD
Levobunolol—Diarrhoea—Melphalan—breast cancer	0.00106	0.00116	CcSEcCtD
Levobunolol—Diplopia—Epirubicin—breast cancer	0.00106	0.00116	CcSEcCtD
Levobunolol—Nausea—Chlorambucil—breast cancer	0.00105	0.00115	CcSEcCtD
Levobunolol—Visual impairment—Docetaxel—breast cancer	0.00104	0.00114	CcSEcCtD
Levobunolol—Dizziness—Tamoxifen—breast cancer	0.00104	0.00114	CcSEcCtD
Levobunolol—Hypotension—Irinotecan—breast cancer	0.00104	0.00114	CcSEcCtD
Levobunolol—Hypotension—Mitoxantrone—breast cancer	0.00104	0.00114	CcSEcCtD
Levobunolol—Diarrhoea—Goserelin—breast cancer	0.00103	0.00113	CcSEcCtD
Levobunolol—Erythema multiforme—Docetaxel—breast cancer	0.00102	0.00112	CcSEcCtD
Levobunolol—Urticaria—Thiotepa—breast cancer	0.00102	0.00112	CcSEcCtD
Levobunolol—Headache—Vinblastine—breast cancer	0.00102	0.00111	CcSEcCtD
Levobunolol—Propranolol—CYP1A1—breast cancer	0.00101	0.0685	CrCbGaD
Levobunolol—Hypotension—Gemcitabine—breast cancer	0.00101	0.00111	CcSEcCtD
Levobunolol—Visual impairment—Capecitabine—breast cancer	0.00101	0.00111	CcSEcCtD
Levobunolol—Cardiac arrest—Epirubicin—breast cancer	0.001	0.0011	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—breast cancer	0.001	0.0011	CcSEcCtD
Levobunolol—Paraesthesia—Mitoxantrone—breast cancer	0.000999	0.00109	CcSEcCtD
Levobunolol—Paraesthesia—Irinotecan—breast cancer	0.000999	0.00109	CcSEcCtD
Levobunolol—Syncope—Paclitaxel—breast cancer	0.000997	0.00109	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—breast cancer	0.000997	0.00109	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—breast cancer	0.000997	0.00109	CcSEcCtD
Levobunolol—Dizziness—Goserelin—breast cancer	0.000996	0.00109	CcSEcCtD
Levobunolol—Hypotension—Fluorouracil—breast cancer	0.000996	0.00109	CcSEcCtD
Levobunolol—Hypersensitivity—Vinorelbine—breast cancer	0.000994	0.00109	CcSEcCtD
Levobunolol—Ataxia—Epirubicin—breast cancer	0.000992	0.00109	CcSEcCtD
Levobunolol—Dyspnoea—Mitoxantrone—breast cancer	0.000992	0.00109	CcSEcCtD
Levobunolol—Dyspnoea—Irinotecan—breast cancer	0.000992	0.00109	CcSEcCtD
Levobunolol—Erythema multiforme—Capecitabine—breast cancer	0.000991	0.00109	CcSEcCtD
Levobunolol—Headache—Tamoxifen—breast cancer	0.000988	0.00108	CcSEcCtD
Levobunolol—Palpitations—Paclitaxel—breast cancer	0.000982	0.00108	CcSEcCtD
Levobunolol—Loss of consciousness—Paclitaxel—breast cancer	0.000977	0.00107	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—breast cancer	0.000977	0.00107	CcSEcCtD
Levobunolol—Paraesthesia—Gemcitabine—breast cancer	0.000973	0.00107	CcSEcCtD
Levobunolol—Asthenia—Vinorelbine—breast cancer	0.000968	0.00106	CcSEcCtD
Levobunolol—Arrhythmia—Docetaxel—breast cancer	0.000967	0.00106	CcSEcCtD
Levobunolol—Dyspnoea—Gemcitabine—breast cancer	0.000966	0.00106	CcSEcCtD
Levobunolol—Nausea—Vinblastine—breast cancer	0.000964	0.00106	CcSEcCtD
Levobunolol—Paraesthesia—Fluorouracil—breast cancer	0.000957	0.00105	CcSEcCtD
Levobunolol—Alopecia—Docetaxel—breast cancer	0.000957	0.00105	CcSEcCtD
Levobunolol—Pruritus—Vinorelbine—breast cancer	0.000954	0.00105	CcSEcCtD
Levobunolol—Pain—Mitoxantrone—breast cancer	0.000951	0.00104	CcSEcCtD
Levobunolol—Pain—Irinotecan—breast cancer	0.000951	0.00104	CcSEcCtD
Levobunolol—Dyspnoea—Fluorouracil—breast cancer	0.00095	0.00104	CcSEcCtD
Levobunolol—Hypersensitivity—Thiotepa—breast cancer	0.000949	0.00104	CcSEcCtD
Levobunolol—Chest pain—Paclitaxel—breast cancer	0.000947	0.00104	CcSEcCtD
Levobunolol—Headache—Goserelin—breast cancer	0.000944	0.00103	CcSEcCtD
Levobunolol—Nausea—Tamoxifen—breast cancer	0.000937	0.00103	CcSEcCtD
Levobunolol—Arrhythmia—Capecitabine—breast cancer	0.000936	0.00103	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—breast cancer	0.000929	0.00102	CcSEcCtD
Levobunolol—Pain—Gemcitabine—breast cancer	0.000927	0.00102	CcSEcCtD
Levobunolol—Alopecia—Capecitabine—breast cancer	0.000926	0.00101	CcSEcCtD
Levobunolol—Asthenia—Thiotepa—breast cancer	0.000924	0.00101	CcSEcCtD
Levobunolol—Diarrhoea—Vinorelbine—breast cancer	0.000923	0.00101	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—breast cancer	0.000918	0.00101	CcSEcCtD
Levobunolol—Nausea—Melphalan—breast cancer	0.000917	0.001	CcSEcCtD
Levobunolol—Feeling abnormal—Irinotecan—breast cancer	0.000917	0.001	CcSEcCtD
Levobunolol—Feeling abnormal—Mitoxantrone—breast cancer	0.000917	0.001	CcSEcCtD
Levobunolol—Confusional state—Paclitaxel—breast cancer	0.000915	0.001	CcSEcCtD
Levobunolol—Pruritus—Thiotepa—breast cancer	0.000911	0.000998	CcSEcCtD
Levobunolol—Pain—Fluorouracil—breast cancer	0.000911	0.000998	CcSEcCtD
Levobunolol—Erectile dysfunction—Methotrexate—breast cancer	0.000898	0.000983	CcSEcCtD
Levobunolol—Nausea—Goserelin—breast cancer	0.000895	0.00098	CcSEcCtD
Levobunolol—Feeling abnormal—Gemcitabine—breast cancer	0.000893	0.000978	CcSEcCtD
Levobunolol—Shock—Paclitaxel—breast cancer	0.000893	0.000978	CcSEcCtD
Levobunolol—Dizziness—Vinorelbine—breast cancer	0.000892	0.000977	CcSEcCtD
Levobunolol—Urticaria—Mitoxantrone—breast cancer	0.000884	0.000968	CcSEcCtD
Levobunolol—Diarrhoea—Thiotepa—breast cancer	0.000881	0.000966	CcSEcCtD
Levobunolol—Feeling abnormal—Fluorouracil—breast cancer	0.000878	0.000962	CcSEcCtD
Levobunolol—Depression—Methotrexate—breast cancer	0.000867	0.000949	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000862	0.000944	CcSEcCtD
Levobunolol—Dizziness—Thiotepa—breast cancer	0.000852	0.000933	CcSEcCtD
Levobunolol—Hypotension—Paclitaxel—breast cancer	0.000848	0.000929	CcSEcCtD
Levobunolol—Urticaria—Fluorouracil—breast cancer	0.000846	0.000927	CcSEcCtD
Levobunolol—Headache—Vinorelbine—breast cancer	0.000845	0.000926	CcSEcCtD
Levobunolol—Syncope—Docetaxel—breast cancer	0.000845	0.000926	CcSEcCtD
Levobunolol—Conjunctivitis—Methotrexate—breast cancer	0.000845	0.000925	CcSEcCtD
Levobunolol—Palpitations—Docetaxel—breast cancer	0.000833	0.000912	CcSEcCtD
Levobunolol—Loss of consciousness—Docetaxel—breast cancer	0.000828	0.000907	CcSEcCtD
Levobunolol—Hypersensitivity—Mitoxantrone—breast cancer	0.00082	0.000898	CcSEcCtD
Levobunolol—Hypersensitivity—Irinotecan—breast cancer	0.00082	0.000898	CcSEcCtD
Levobunolol—Syncope—Capecitabine—breast cancer	0.000818	0.000896	CcSEcCtD
Levobunolol—Paraesthesia—Paclitaxel—breast cancer	0.000815	0.000893	CcSEcCtD
Levobunolol—Dyspnoea—Paclitaxel—breast cancer	0.000809	0.000886	CcSEcCtD
Levobunolol—Headache—Thiotepa—breast cancer	0.000807	0.000884	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000806	0.000883	CcSEcCtD
Levobunolol—Palpitations—Capecitabine—breast cancer	0.000806	0.000883	CcSEcCtD
Levobunolol—Chest pain—Docetaxel—breast cancer	0.000802	0.000879	CcSEcCtD
Levobunolol—Loss of consciousness—Capecitabine—breast cancer	0.000802	0.000878	CcSEcCtD
Levobunolol—Nausea—Vinorelbine—breast cancer	0.000801	0.000878	CcSEcCtD
Levobunolol—Asthenia—Mitoxantrone—breast cancer	0.000798	0.000874	CcSEcCtD
Levobunolol—Asthenia—Irinotecan—breast cancer	0.000798	0.000874	CcSEcCtD
Levobunolol—Conjunctivitis—Epirubicin—breast cancer	0.000791	0.000866	CcSEcCtD
Levobunolol—Hypersensitivity—Fluorouracil—breast cancer	0.000785	0.00086	CcSEcCtD
Levobunolol—Asthenia—Gemcitabine—breast cancer	0.000778	0.000852	CcSEcCtD
Levobunolol—Chest pain—Capecitabine—breast cancer	0.000777	0.000851	CcSEcCtD
Levobunolol—Pain—Paclitaxel—breast cancer	0.000776	0.00085	CcSEcCtD
Levobunolol—Confusional state—Docetaxel—breast cancer	0.000775	0.000849	CcSEcCtD
Levobunolol—Pruritus—Gemcitabine—breast cancer	0.000767	0.00084	CcSEcCtD
Levobunolol—Nausea—Thiotepa—breast cancer	0.000765	0.000838	CcSEcCtD
Levobunolol—Diarrhoea—Irinotecan—breast cancer	0.000761	0.000834	CcSEcCtD
Levobunolol—Diarrhoea—Mitoxantrone—breast cancer	0.000761	0.000834	CcSEcCtD
Levobunolol—Shock—Docetaxel—breast cancer	0.000757	0.000829	CcSEcCtD
Levobunolol—Propranolol—CYP2D6—breast cancer	0.000754	0.0509	CrCbGaD
Levobunolol—Pruritus—Fluorouracil—breast cancer	0.000754	0.000826	CcSEcCtD
Levobunolol—Visual impairment—Methotrexate—breast cancer	0.000752	0.000824	CcSEcCtD
Levobunolol—Confusional state—Capecitabine—breast cancer	0.000751	0.000822	CcSEcCtD
Levobunolol—Feeling abnormal—Paclitaxel—breast cancer	0.000748	0.000819	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000746	0.000817	CcSEcCtD
Levobunolol—Bradycardia—Epirubicin—breast cancer	0.000743	0.000814	CcSEcCtD
Levobunolol—Diarrhoea—Gemcitabine—breast cancer	0.000742	0.000812	CcSEcCtD
Levobunolol—Erythema multiforme—Methotrexate—breast cancer	0.000738	0.000808	CcSEcCtD
Levobunolol—Dizziness—Irinotecan—breast cancer	0.000736	0.000806	CcSEcCtD
Levobunolol—Shock—Capecitabine—breast cancer	0.000733	0.000802	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—breast cancer	0.000732	0.000801	CcSEcCtD
Levobunolol—Diarrhoea—Fluorouracil—breast cancer	0.000729	0.000799	CcSEcCtD
Levobunolol—Urticaria—Paclitaxel—breast cancer	0.000721	0.00079	CcSEcCtD
Levobunolol—Hypotension—Docetaxel—breast cancer	0.000719	0.000787	CcSEcCtD
Levobunolol—Dizziness—Fluorouracil—breast cancer	0.000705	0.000772	CcSEcCtD
Levobunolol—Visual impairment—Epirubicin—breast cancer	0.000704	0.000771	CcSEcCtD
Levobunolol—Headache—Mitoxantrone—breast cancer	0.000697	0.000763	CcSEcCtD
Levobunolol—Headache—Irinotecan—breast cancer	0.000697	0.000763	CcSEcCtD
Levobunolol—Hypotension—Capecitabine—breast cancer	0.000696	0.000762	CcSEcCtD
Levobunolol—Paraesthesia—Docetaxel—breast cancer	0.000691	0.000756	CcSEcCtD
Levobunolol—Erythema multiforme—Epirubicin—breast cancer	0.00069	0.000756	CcSEcCtD
Levobunolol—Alopecia—Methotrexate—breast cancer	0.000689	0.000755	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—breast cancer	0.000688	0.000753	CcSEcCtD
Levobunolol—Dyspnoea—Docetaxel—breast cancer	0.000686	0.000751	CcSEcCtD
Levobunolol—Headache—Gemcitabine—breast cancer	0.000679	0.000744	CcSEcCtD
Levobunolol—Paraesthesia—Capecitabine—breast cancer	0.000669	0.000732	CcSEcCtD
Levobunolol—Hypersensitivity—Paclitaxel—breast cancer	0.000669	0.000732	CcSEcCtD
Levobunolol—Headache—Fluorouracil—breast cancer	0.000668	0.000731	CcSEcCtD
Levobunolol—Dyspnoea—Capecitabine—breast cancer	0.000664	0.000727	CcSEcCtD
Levobunolol—Nausea—Mitoxantrone—breast cancer	0.000661	0.000724	CcSEcCtD
Levobunolol—Nausea—Irinotecan—breast cancer	0.000661	0.000724	CcSEcCtD
Levobunolol—Pain—Docetaxel—breast cancer	0.000658	0.00072	CcSEcCtD
Levobunolol—Arrhythmia—Epirubicin—breast cancer	0.000652	0.000715	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—breast cancer	0.000651	0.000713	CcSEcCtD
Levobunolol—Asthenia—Paclitaxel—breast cancer	0.000651	0.000713	CcSEcCtD
Levobunolol—Propranolol—CYP3A4—breast cancer	0.000647	0.0437	CrCbGaD
Levobunolol—Alopecia—Epirubicin—breast cancer	0.000645	0.000707	CcSEcCtD
Levobunolol—Nausea—Gemcitabine—breast cancer	0.000644	0.000705	CcSEcCtD
Levobunolol—Pruritus—Paclitaxel—breast cancer	0.000642	0.000703	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—breast cancer	0.000639	0.0007	CcSEcCtD
Levobunolol—Pain—Capecitabine—breast cancer	0.000637	0.000698	CcSEcCtD
Levobunolol—Feeling abnormal—Docetaxel—breast cancer	0.000634	0.000694	CcSEcCtD
Levobunolol—Nausea—Fluorouracil—breast cancer	0.000633	0.000693	CcSEcCtD
Levobunolol—Diarrhoea—Paclitaxel—breast cancer	0.000621	0.00068	CcSEcCtD
Levobunolol—Feeling abnormal—Capecitabine—breast cancer	0.000614	0.000672	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—breast cancer	0.000604	0.000661	CcSEcCtD
Levobunolol—Dizziness—Paclitaxel—breast cancer	0.0006	0.000657	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—breast cancer	0.000597	0.000654	CcSEcCtD
Levobunolol—Urticaria—Capecitabine—breast cancer	0.000592	0.000648	CcSEcCtD
Levobunolol—Chest pain—Methotrexate—breast cancer	0.000578	0.000633	CcSEcCtD
Levobunolol—Syncope—Epirubicin—breast cancer	0.00057	0.000624	CcSEcCtD
Levobunolol—Headache—Paclitaxel—breast cancer	0.000568	0.000623	CcSEcCtD
Levobunolol—Hypersensitivity—Docetaxel—breast cancer	0.000567	0.000621	CcSEcCtD
Levobunolol—Palpitations—Epirubicin—breast cancer	0.000562	0.000615	CcSEcCtD
Levobunolol—Confusional state—Methotrexate—breast cancer	0.000559	0.000612	CcSEcCtD
Levobunolol—Loss of consciousness—Epirubicin—breast cancer	0.000559	0.000612	CcSEcCtD
Levobunolol—Asthenia—Docetaxel—breast cancer	0.000552	0.000604	CcSEcCtD
Levobunolol—Hypersensitivity—Capecitabine—breast cancer	0.000549	0.000601	CcSEcCtD
Levobunolol—Pruritus—Docetaxel—breast cancer	0.000544	0.000596	CcSEcCtD
Levobunolol—Chest pain—Epirubicin—breast cancer	0.000541	0.000593	CcSEcCtD
Levobunolol—Nausea—Paclitaxel—breast cancer	0.000539	0.00059	CcSEcCtD
Levobunolol—Propranolol—ABCB1—breast cancer	0.000538	0.0364	CrCbGaD
Levobunolol—Asthenia—Capecitabine—breast cancer	0.000534	0.000585	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—breast cancer	0.000527	0.000578	CcSEcCtD
Levobunolol—Pruritus—Capecitabine—breast cancer	0.000527	0.000577	CcSEcCtD
Levobunolol—Diarrhoea—Docetaxel—breast cancer	0.000526	0.000576	CcSEcCtD
Levobunolol—Confusional state—Epirubicin—breast cancer	0.000523	0.000573	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—breast cancer	0.00052	0.000569	CcSEcCtD
Levobunolol—Hypotension—Methotrexate—breast cancer	0.000518	0.000567	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—breast cancer	0.000517	0.000566	CcSEcCtD
Levobunolol—Shock—Epirubicin—breast cancer	0.00051	0.000559	CcSEcCtD
Levobunolol—Diarrhoea—Capecitabine—breast cancer	0.000509	0.000558	CcSEcCtD
Levobunolol—Dizziness—Docetaxel—breast cancer	0.000509	0.000557	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—breast cancer	0.000501	0.000548	CcSEcCtD
Levobunolol—Paraesthesia—Methotrexate—breast cancer	0.000498	0.000545	CcSEcCtD
Levobunolol—Dyspnoea—Methotrexate—breast cancer	0.000494	0.000541	CcSEcCtD
Levobunolol—Dizziness—Capecitabine—breast cancer	0.000492	0.000539	CcSEcCtD
Levobunolol—Hypotension—Epirubicin—breast cancer	0.000485	0.000531	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—breast cancer	0.000484	0.00053	CcSEcCtD
Levobunolol—Headache—Docetaxel—breast cancer	0.000482	0.000528	CcSEcCtD
Levobunolol—Pain—Methotrexate—breast cancer	0.000474	0.000519	CcSEcCtD
Levobunolol—Shock—Doxorubicin—breast cancer	0.000472	0.000517	CcSEcCtD
Levobunolol—Headache—Capecitabine—breast cancer	0.000466	0.000511	CcSEcCtD
Levobunolol—Paraesthesia—Epirubicin—breast cancer	0.000466	0.00051	CcSEcCtD
Levobunolol—Dyspnoea—Epirubicin—breast cancer	0.000462	0.000507	CcSEcCtD
Levobunolol—Nausea—Docetaxel—breast cancer	0.000457	0.0005	CcSEcCtD
Levobunolol—Feeling abnormal—Methotrexate—breast cancer	0.000457	0.0005	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—breast cancer	0.000449	0.000491	CcSEcCtD
Levobunolol—Pain—Epirubicin—breast cancer	0.000444	0.000486	CcSEcCtD
Levobunolol—Nausea—Capecitabine—breast cancer	0.000442	0.000484	CcSEcCtD
Levobunolol—Urticaria—Methotrexate—breast cancer	0.00044	0.000482	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—breast cancer	0.000431	0.000472	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—breast cancer	0.000428	0.000469	CcSEcCtD
Levobunolol—Feeling abnormal—Epirubicin—breast cancer	0.000427	0.000468	CcSEcCtD
Levobunolol—Urticaria—Epirubicin—breast cancer	0.000412	0.000451	CcSEcCtD
Levobunolol—Pain—Doxorubicin—breast cancer	0.00041	0.00045	CcSEcCtD
Levobunolol—Hypersensitivity—Methotrexate—breast cancer	0.000408	0.000447	CcSEcCtD
Levobunolol—Asthenia—Methotrexate—breast cancer	0.000398	0.000436	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—breast cancer	0.000396	0.000433	CcSEcCtD
Levobunolol—Pruritus—Methotrexate—breast cancer	0.000392	0.00043	CcSEcCtD
Levobunolol—Hypersensitivity—Epirubicin—breast cancer	0.000382	0.000419	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—breast cancer	0.000381	0.000418	CcSEcCtD
Levobunolol—Diarrhoea—Methotrexate—breast cancer	0.000379	0.000415	CcSEcCtD
Levobunolol—Asthenia—Epirubicin—breast cancer	0.000372	0.000408	CcSEcCtD
Levobunolol—Pruritus—Epirubicin—breast cancer	0.000367	0.000402	CcSEcCtD
Levobunolol—Dizziness—Methotrexate—breast cancer	0.000367	0.000402	CcSEcCtD
Levobunolol—Diarrhoea—Epirubicin—breast cancer	0.000355	0.000389	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—breast cancer	0.000354	0.000387	CcSEcCtD
Levobunolol—Headache—Methotrexate—breast cancer	0.000347	0.00038	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—breast cancer	0.000344	0.000377	CcSEcCtD
Levobunolol—Dizziness—Epirubicin—breast cancer	0.000343	0.000376	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—breast cancer	0.00034	0.000372	CcSEcCtD
Levobunolol—Nausea—Methotrexate—breast cancer	0.000329	0.000361	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—breast cancer	0.000328	0.00036	CcSEcCtD
Levobunolol—Headache—Epirubicin—breast cancer	0.000325	0.000356	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—breast cancer	0.000317	0.000348	CcSEcCtD
Levobunolol—Nausea—Epirubicin—breast cancer	0.000308	0.000338	CcSEcCtD
Levobunolol—Headache—Doxorubicin—breast cancer	0.000301	0.000329	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—breast cancer	0.000285	0.000312	CcSEcCtD
Levobunolol—ADRB2—Signaling Pathways—VEGFC—breast cancer	5.27e-05	0.000729	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—WNT1—breast cancer	5.23e-05	0.000723	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PLA2G4A—breast cancer	5.22e-05	0.000721	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JAG2—breast cancer	5.19e-05	0.000718	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CSF2—breast cancer	5.16e-05	0.000713	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—WNT1—breast cancer	5.11e-05	0.000707	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PLA2G4A—breast cancer	5.1e-05	0.000706	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CSF2—breast cancer	5.05e-05	0.000698	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH4—breast cancer	4.96e-05	0.000685	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GZMB—breast cancer	4.93e-05	0.000681	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH4—breast cancer	4.85e-05	0.00067	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GZMB—breast cancer	4.82e-05	0.000666	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL2—breast cancer	4.78e-05	0.000661	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR2—breast cancer	4.78e-05	0.000661	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTHLH—breast cancer	4.73e-05	0.000654	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BMP2—breast cancer	4.73e-05	0.000654	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL2—breast cancer	4.68e-05	0.000647	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR2—breast cancer	4.68e-05	0.000647	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTHLH—breast cancer	4.62e-05	0.00064	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BMP2—breast cancer	4.62e-05	0.00064	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDNRB—breast cancer	4.58e-05	0.000633	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PGR—breast cancer	4.53e-05	0.000627	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—THBS1—breast cancer	4.51e-05	0.000624	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDNRB—breast cancer	4.48e-05	0.000619	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PGR—breast cancer	4.43e-05	0.000613	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—THBS1—breast cancer	4.41e-05	0.00061	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FLT1—breast cancer	4.31e-05	0.000595	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SQSTM1—breast cancer	4.29e-05	0.000593	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF3—breast cancer	4.29e-05	0.000593	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CG—breast cancer	4.26e-05	0.00059	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JAG1—breast cancer	4.23e-05	0.000585	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH3—breast cancer	4.21e-05	0.000583	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PARP1—breast cancer	4.21e-05	0.000583	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FLT1—breast cancer	4.21e-05	0.000582	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF3—breast cancer	4.19e-05	0.00058	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SQSTM1—breast cancer	4.19e-05	0.00058	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CG—breast cancer	4.17e-05	0.000577	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CALCA—breast cancer	4.16e-05	0.000576	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JAG1—breast cancer	4.14e-05	0.000572	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH3—breast cancer	4.12e-05	0.00057	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PARP1—breast cancer	4.12e-05	0.00057	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RPS6—breast cancer	4.11e-05	0.000569	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF4—breast cancer	4.08e-05	0.000564	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CALCA—breast cancer	4.07e-05	0.000563	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL12—breast cancer	4.07e-05	0.000562	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCR4—breast cancer	4.07e-05	0.000562	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RPS6—breast cancer	4.02e-05	0.000556	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF4—breast cancer	3.99e-05	0.000552	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PAK1—breast cancer	3.99e-05	0.000552	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCR4—breast cancer	3.98e-05	0.00055	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL12—breast cancer	3.98e-05	0.00055	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TCF7L2—breast cancer	3.92e-05	0.000542	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PAK1—breast cancer	3.9e-05	0.00054	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT2—breast cancer	3.9e-05	0.00054	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CG—breast cancer	3.87e-05	0.000536	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TCF7L2—breast cancer	3.83e-05	0.00053	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT2—breast cancer	3.82e-05	0.000528	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	3.79e-05	0.000524	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	3.78e-05	0.000523	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH2—breast cancer	3.78e-05	0.000523	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	3.75e-05	0.000518	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	3.7e-05	0.000511	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH2—breast cancer	3.7e-05	0.000511	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR1—breast cancer	3.68e-05	0.000508	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRL—breast cancer	3.68e-05	0.000508	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	3.67e-05	0.000507	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STK11—breast cancer	3.62e-05	0.000501	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADAM10—breast cancer	3.62e-05	0.000501	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR1—breast cancer	3.6e-05	0.000497	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRL—breast cancer	3.6e-05	0.000497	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLG—breast cancer	3.58e-05	0.000496	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STK11—breast cancer	3.54e-05	0.00049	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADAM10—breast cancer	3.54e-05	0.00049	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT2—breast cancer	3.54e-05	0.00049	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF10—breast cancer	3.53e-05	0.000487	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLG—breast cancer	3.51e-05	0.000485	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT2—breast cancer	3.47e-05	0.000479	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF10—breast cancer	3.45e-05	0.000477	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	3.4e-05	0.000471	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PDGFA—breast cancer	3.4e-05	0.00047	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	3.35e-05	0.000464	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	3.33e-05	0.000461	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PDGFA—breast cancer	3.33e-05	0.00046	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ITPR1—breast cancer	3.3e-05	0.000456	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	3.28e-05	0.000454	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STAT5A—breast cancer	3.28e-05	0.000453	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ERBB4—breast cancer	3.28e-05	0.000453	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP3—breast cancer	3.28e-05	0.000453	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	3.27e-05	0.000452	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ITPR1—breast cancer	3.23e-05	0.000446	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP3—breast cancer	3.21e-05	0.000443	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ERBB4—breast cancer	3.21e-05	0.000443	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STAT5A—breast cancer	3.21e-05	0.000443	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	3.2e-05	0.000442	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SMAD4—breast cancer	3.17e-05	0.000439	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1R—breast cancer	3.15e-05	0.000436	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	3.14e-05	0.000434	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SMAD4—breast cancer	3.1e-05	0.000429	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HES1—breast cancer	3.1e-05	0.000429	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1R—breast cancer	3.09e-05	0.000427	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NCOR1—breast cancer	3.08e-05	0.000426	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	3.08e-05	0.000426	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	3.07e-05	0.000425	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF1—breast cancer	3.05e-05	0.000421	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CSF2—breast cancer	3.05e-05	0.000421	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RAF1—breast cancer	3.04e-05	0.00042	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HES1—breast cancer	3.03e-05	0.000419	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NRG1—breast cancer	3.02e-05	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	3.01e-05	0.000417	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NCOR1—breast cancer	3.01e-05	0.000417	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—H2AFX—breast cancer	3e-05	0.000415	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—IL2—breast cancer	3e-05	0.000415	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—E2F1—breast cancer	2.98e-05	0.000412	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF1—breast cancer	2.98e-05	0.000412	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CSF2—breast cancer	2.98e-05	0.000412	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RAF1—breast cancer	2.97e-05	0.000411	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	2.97e-05	0.00041	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NRG1—breast cancer	2.96e-05	0.000409	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—H2AFX—breast cancer	2.94e-05	0.000406	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—IL2—breast cancer	2.94e-05	0.000406	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—E2F1—breast cancer	2.92e-05	0.000403	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	2.9e-05	0.000401	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SPP1—breast cancer	2.86e-05	0.000396	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	2.85e-05	0.000394	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ERBB3—breast cancer	2.83e-05	0.000392	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGFR2—breast cancer	2.83e-05	0.000391	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SPP1—breast cancer	2.8e-05	0.000388	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	2.79e-05	0.000386	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ERBB3—breast cancer	2.77e-05	0.000383	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGFR2—breast cancer	2.77e-05	0.000383	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL2—breast cancer	2.73e-05	0.000377	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TERT—breast cancer	2.72e-05	0.000376	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL2—breast cancer	2.67e-05	0.000369	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TERT—breast cancer	2.66e-05	0.000367	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	2.64e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	2.6e-05	0.000359	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	2.58e-05	0.000357	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	2.54e-05	0.000351	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—breast cancer	2.54e-05	0.000351	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CAV1—breast cancer	2.51e-05	0.000347	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KDR—breast cancer	2.48e-05	0.000343	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—breast cancer	2.48e-05	0.000343	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CAV1—breast cancer	2.46e-05	0.00034	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KDR—breast cancer	2.43e-05	0.000336	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ESR1—breast cancer	2.42e-05	0.000335	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FN1—breast cancer	2.39e-05	0.000331	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ESR1—breast cancer	2.37e-05	0.000327	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	2.36e-05	0.000327	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	2.34e-05	0.000324	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FN1—breast cancer	2.34e-05	0.000323	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	2.31e-05	0.00032	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	2.29e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KIT—breast cancer	2.29e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APC—breast cancer	2.29e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	2.29e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EGF—breast cancer	2.26e-05	0.000313	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KIT—breast cancer	2.24e-05	0.00031	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APC—breast cancer	2.24e-05	0.00031	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	2.24e-05	0.00031	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EGF—breast cancer	2.21e-05	0.000306	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	2.19e-05	0.000303	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BRAF—breast cancer	2.15e-05	0.000297	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	2.14e-05	0.000296	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BRAF—breast cancer	2.1e-05	0.000291	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1—breast cancer	2.09e-05	0.00029	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT2—breast cancer	2.09e-05	0.000289	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	2.08e-05	0.000288	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1—breast cancer	2.05e-05	0.000283	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT2—breast cancer	2.05e-05	0.000283	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	2.04e-05	0.000282	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	2.01e-05	0.000278	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	1.99e-05	0.000276	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	1.99e-05	0.000275	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	1.97e-05	0.000272	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	1.97e-05	0.000272	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	1.95e-05	0.00027	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	1.95e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	1.93e-05	0.000266	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOS3—breast cancer	1.9e-05	0.000263	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOS3—breast cancer	1.86e-05	0.000257	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	1.81e-05	0.00025	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MDM2—breast cancer	1.8e-05	0.000249	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RAF1—breast cancer	1.8e-05	0.000248	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RELA—breast cancer	1.79e-05	0.000247	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	1.78e-05	0.000246	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	1.77e-05	0.000245	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MDM2—breast cancer	1.76e-05	0.000244	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RAF1—breast cancer	1.76e-05	0.000243	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MTOR—breast cancer	1.75e-05	0.000242	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	1.75e-05	0.000242	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RELA—breast cancer	1.75e-05	0.000242	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	1.74e-05	0.00024	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	1.71e-05	0.000237	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MTOR—breast cancer	1.71e-05	0.000237	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.68e-05	0.000233	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.67e-05	0.000231	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	1.65e-05	0.000228	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.65e-05	0.000228	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	1.64e-05	0.000226	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.63e-05	0.000225	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—breast cancer	1.61e-05	0.000223	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL2—breast cancer	1.61e-05	0.000223	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	1.61e-05	0.000223	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—breast cancer	1.6e-05	0.000222	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	1.59e-05	0.00022	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—breast cancer	1.58e-05	0.000218	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL2—breast cancer	1.57e-05	0.000218	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCND1—breast cancer	1.57e-05	0.000217	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—breast cancer	1.57e-05	0.000217	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JUN—breast cancer	1.57e-05	0.000217	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.55e-05	0.000215	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCND1—breast cancer	1.54e-05	0.000212	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JUN—breast cancer	1.53e-05	0.000212	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP9—breast cancer	1.52e-05	0.000211	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	1.52e-05	0.00021	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.52e-05	0.00021	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTEN—breast cancer	1.51e-05	0.000209	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP9—breast cancer	1.49e-05	0.000206	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.49e-05	0.000205	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.48e-05	0.000205	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTEN—breast cancer	1.48e-05	0.000205	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.48e-05	0.000204	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.45e-05	0.0002	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.45e-05	0.0002	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SRC—breast cancer	1.4e-05	0.000194	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SRC—breast cancer	1.37e-05	0.00019	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.37e-05	0.000189	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STAT3—breast cancer	1.35e-05	0.000187	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.34e-05	0.000185	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STAT3—breast cancer	1.33e-05	0.000183	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.29e-05	0.000179	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.27e-05	0.000175	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MYC—breast cancer	1.26e-05	0.000174	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.26e-05	0.000174	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MYC—breast cancer	1.23e-05	0.00017	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EGFR—breast cancer	1.23e-05	0.00017	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.23e-05	0.00017	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EGFR—breast cancer	1.2e-05	0.000167	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KRAS—breast cancer	1.16e-05	0.000161	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KRAS—breast cancer	1.14e-05	0.000157	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.07e-05	0.000148	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	1.05e-05	0.000145	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TP53—breast cancer	1.03e-05	0.000143	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TP53—breast cancer	1.01e-05	0.00014	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HRAS—breast cancer	9.89e-06	0.000137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HRAS—breast cancer	9.67e-06	0.000134	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—breast cancer	9.46e-06	0.000131	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—breast cancer	9.26e-06	0.000128	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT1—breast cancer	8.73e-06	0.000121	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT1—breast cancer	8.54e-06	0.000118	CbGpPWpGaD
